We serve Chemical Name:2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methylpropan-1-amine CAS:891642-99-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methylpropan-1-amine
CAS.NO:891642-99-2
Synonyms:2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methylpropan-1-amine
Molecular Formula:C13H20N2
Molecular Weight:204.31100
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:308.235ºC at 760 mmHg
Density:1.036g/cm3
Index of Refraction:1.559
PSA:29.26000
Exact Mass:204.16300
LogP:2.42020
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methylpropan-1-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methylpropan-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methylpropan-1-amine Use and application,2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-methylpropan-1-amine technical grade,usp/ep/jp grade.
Related News: After the collapse of the South Florida apartment complex, organizations like the Global Empowerment Mission (GEM) and Bstrong quickly mobilized to help combat the aftermath of the disaster. Now, surviving residents need much more than just the initial aid of GEM Bstrong cash cards, and the short term condo apartments provided for 30-60 days during the interim. 3,4-dimethyl-2-(2-(phenylamino)vinyl)thiazol-3-ium-5-carboxylate manufacturers The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics. Cyclobutanone, 2,2-dibromo-4,4-dichloro-3-ethoxy- suppliers Brian McNamara, currently head of GSK’s consumer healthcare division, will continue to serve as the franchise’s CEO after it breaks away from GSK in 2022, the British pharma said Thursday. 4-((4-(4-(2-morpholinoethyl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)pyrimidin-2-yl)amino)benzenesulfonamide vendor & factory.
